How to Buy Evommune Stock
Evommune Inc
Evommune is a biotech company located in California, United States, which is part of the Healthcare sector, and is traded under the ticker EVMN on the NYSE exchange.
Evommune stock last closed at $22.18, down 6.29% from the previous day, and has decreased N/A in one year. It has underperformed other stocks in the Biotechnology industry by N/A percentage points. Evommune stock is currently +59.74% from its 52-week low of $13.89, and -33.19% from its 52-week high of $33.20.
As of Mar 27, 2026, there are 36.02M shares of EVMN outstanding. The market cap of EVMN is $798.89M. In the past 24 hours, 201,000 EVMN shares were traded.
How to Buy Evommune Stock
Wondering how to invest in Evommune stock? Here's how.
- Decide where to buy Evommune stock: You need to choose an online brokerage, but don't worry - we've analyzed dozens of online stock brokerages and apps to help you choose where to buy Evommune stock.
- Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Fund your brokerage account: Pick your method of payment and add your information.
- Analyze Evommune stock: The Evommune ticker symbol is EVMN. Is Evommune stock a good investment? Should you buy shares of EVMN? How do EVMN's underlying business fundamentals look? Do top analysts think Evommune is a good buy? Why has EVMN's stock price moved recently? (Hint: Our stock market analysis website can help you evaluate if EVMN is a good stock to buy).
- Execute your EVMN purchase: Decide if you will purchase EVMN shares at the current market price or use a limit order to purchase EVMN shares at a particular price.
- Get notifications regarding your investment in EVMN: Create a watchlist to watch your position in Evommune shares.
Step 1: Decide where to buy Evommune stock
You need an online brokerage account to access the NYSE market and buy EVMN shares.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best stock brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to global financial markets: From Technology to Real Estate, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro offers a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've picked the right brokerage, the next step is to fill out some personal details so you are able to invest in EVMN today.
How to Open a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to create your new trading account.
- Send your information by hitting the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you have opened your account on the best stock app, your next step is to transfer the money for your investment:
Check out the walkthrough below for more details transferring money into your new brokerage account.
Step 4: Analyze Evommune stock
Once you have figured out the best place to buy Evommune stock, it's critical to analyze their stock prior to investing, so you actually comprehend the risk as well as the opportunity.
Evommune Numbers
Evommune Fundamentals
WallStreetZen was created to help everyday investors perform better fundamental analysis in less time.
You can see all of the due diligence checks on EVMN's stock page.
How is EVMN stock valued?
You can use many financial metrics, analyses, models, and charts to gauge EVMN's intrinsic value.
Using relative valuations measures:
- EVMN could be undervalued based on its P/B ratio of 3.89x, relative to Biotechnology industry P/B ratio of 4.52x
You can do additional valuation research on EVMN's stock here.
EVMN Financial Health Overview
Passed Financial Due Diligence Checks:
- EVMN has cash burn of 76676000. It has enough cash and short-term investments to cover this for at least one year.
- EVMN has $150.62M in cash and short term investments. This is sufficient to cover its annual cash burn of $76.68M.
- There are more short-term assets than long-term liabilities on the EVMN balance sheet.
- There are more short-term assets than short-term liabilities on the EVMN balance sheet.
- EVMN has a low debt to equity ratio of 0.09.
Failed Financial Due Diligence Checks:
- EVMN profit margin has gone up by 4.46 percentage points in the past year, but the company is still unprofitable.
Is EVMN stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 7 Equities analysts who track EVMN, the consensus analyst rating on Evommune is a Strong Buy
It's important to note that analyst ratings are not recommendations, nor are they financial advice.
Latest EVMN Analyst Upgrades/Downgrades
Thomas Smith, a top 9% analyst from Leerink Partners initiates coverage on EVMN with a buy rating and announces their EVMN price target of $42.00, on Dec 1, 2025.
Gavin Clark-Gartner, a bottom 5% analyst from Evercore ISI Group initiates coverage on EVMN with a buy rating and announces their EVMN price target of $40.00, on Dec 1, 2025.
You can dive deeper into what analysts are saying on the Evommune stock forecast page.
Metrics for Advanced EVMN Traders
EVMN Performance Metrics
Last year, EVMN revenue was $13.00M. Over the past two year, EVMN's revenue has increased by 61.25% per year. This was faster than the Biotechnology industry average of 29%.
Dive into EVMN's earnings and revenue performance here.
Who is buying/selling EVMN?
In the past year, insiders at EVMN have bought more shares than they have sold.
7. Cooperative Ua Lsp, Director of EVMN, was the latest EVMN insider to buy. They bought $9,999,998.40 worth of EVMN shares on Feb 17, 2026.
Dig into more about who owns EVMN shares here.
Can I rely on EVMN as an income stream?
No, Evommune doesn't provide an income stream by paying out dividends.
Get analysis from other traders
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Execute your EVMN purchase
You have two primary types of orders:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are generally the easiest way to buy. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at a given dollar amount limit, use a limit order.
Press the Open button and your broker will execute your order.
If you require additional info about investing in stocks on eToro, click the how to video below:
Step 6: Get notifications regarding your investment in EVMN
Now that you own some shares in EVMN, you'll want to keep up with your new shares.
Create a watchlist to see the latest developments about your EVMN stock.
EVMN Feed
How to Buy Stock in Evommune
To reiterate, here are the 6 steps for buying Evommune stock:
- Decide where to buy Evommune stock
- Sign up for your brokerage account
- Fund your brokerage account
- Analyze Evommune stock
- Execute your EVMN purchase
- Get notifications regarding your investment in EVMN
If you require a brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to track your investment in Evommune, click below.
Other "How To" Guides You Might Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.